10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q2 2010

Filing Information

Form Type	10-Q
Accession Number	`0000897101-10-001618`
Period End Date	20100630
Filing Date	20100811
Fiscal Year	2010
Fiscal Period	Q2
XBRL Instance	stj-20100703.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 56 Cash Flow Statement 55

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$34.95M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$34.23M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$486.57M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$667.05M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $34,229 at July 3, 2010 and $34,947 at January 2, 2010	`AccountsReceivableNetCurrent`	$1.17B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $34,229 at July 3, 2010 and $34,947 at January 2, 2010	`AccountsReceivableNetCurrent`	$1.23B	USD	Point-in-time
Inventories	`InventoryNet`	$662.33M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Inventories	`InventoryNet`	$659.96M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$164.74M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$158.35M	USD	Point-in-time
Other	`OtherAssetsCurrent`	$312.74M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	324.54M	shares	Point-in-time
Other	`OtherAssetsCurrent`	$172.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	327.19M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	324.54M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.56B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	327.19M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.03B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$1.95B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.04B	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$838.17M	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$796.33M	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.15B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.21B	USD	Point-in-time
Goodwill	`Goodwill`	$1.99B	USD	Point-in-time
Goodwill	`Goodwill`	$2.01B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$456.14M	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$424.32M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$279.93M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$250.53M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$6.43B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$6.93B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$334.79M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$150.56M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$132.54M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$13.50M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$269.29M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$271.43M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$317.19M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$246.44M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.07B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$668.43M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.59B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.96B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$138.06M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$132.39M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$314.94M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$344.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.10B	USD	Point-in-time
Total liabilities	`Liabilities`	$3.11B	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 327,187,246 and 324,537,581 shares issued and outstanding at July 3, 2010 and January 2, 2010, respectively)	`CommonStockValue`	$32.72M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 327,187,246 and 324,537,581 shares issued and outstanding at July 3, 2010 and January 2, 2010, respectively)	`CommonStockValue`	$32.45M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$117.92M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.86M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.19B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.68B	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$-35.73M	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$82.03M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$12.00M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$14.59M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.32B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.81B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$6.43B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$6.93B	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$2.32B	USD	2 Qtrs
Net sales	`SalesRevenueNet`	$1.18B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.31B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$2.57B	USD	2 Qtrs
Cost of sales	`CostOfGoodsSold`	$305.54M	USD	1 Quarter
Cost of sales	`CostOfGoodsSold`	$666.47M	USD	2 Qtrs
Cost of sales	`CostOfGoodsSold`	$600.04M	USD	2 Qtrs
Cost of sales	`CostOfGoodsSold`	$345.30M	USD	1 Quarter
Gross profit	`GrossProfit`	$878.87M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.91B	USD	2 Qtrs
Gross profit	`GrossProfit`	$967.47M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.72B	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$848.84M	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$890.90M	USD	2 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$447.61M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$431.17M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$143.05M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$155.10M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$282.40M	USD	2 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$306.33M	USD	2 Qtrs
Operating profit	`OperatingIncomeLoss`	$586.92M	USD	2 Qtrs
Operating profit	`OperatingIncomeLoss`	$710.76M	USD	2 Qtrs
Operating profit	`OperatingIncomeLoss`	$364.75M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$304.65M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-40.55M	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-4.96M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-20.23M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-12.27M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$344.52M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$299.69M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$670.21M	USD	2 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$574.65M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$90.48M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$154.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$177.61M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$80.32M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$219.37M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$254.04M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$492.61M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$420.64M	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.78	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.21	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$1.51	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.63	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.20	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$1.50	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.77	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.63	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	326.11M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	346.77M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	326.92M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	346.31M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	329.31M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	350.21M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	350.62M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	328.68M	shares	2 Qtrs

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`NetIncomeLoss`	$219.37M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$254.04M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$492.61M	USD	2 Qtrs
Net earnings	`NetIncomeLoss`	$420.64M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$100.94M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$115.36M	USD	2 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$454.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$27.98M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$36.44M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$12.87M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$8.00M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$13.41M	USD	2 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$11.39M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$68.78M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$135.36M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$19.86M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$64.86M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$38.14M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$41.36M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-34.08M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$43.62M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-3.13M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$17.43M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$358.46M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$495.38M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$145.75M	USD	2 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$158.48M	USD	2 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$135.60M	USD	2 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$9.06M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$16.15M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-1.33M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-297.50M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-166.21M	USD	2 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$65.19M	USD	2 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$39.59M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$8.00M	USD	2 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$12.87M	USD	2 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$671.09M	USD	2 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$222.00M	USD	2 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$655.72M	USD	2 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$118.77M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$88.56M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$155.68M	USD	2 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.20M	USD	2 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-12.31M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$350.13M	USD	2 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$274.13M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$486.57M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$667.05M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$486.57M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$667.05M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.